DekaBank Deutsche Girozentrale’s Arcturus Therapeutics ARCT Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ARCT Stock Details ARCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-43,889	Closed	-$1.24M	–	1124
2025 Q4	$1.24M	Hold	43,889	–	–	﹤0.01%	838
2025 Q3	$1.23M	Hold	43,889	–	–	﹤0.01%	836
2025 Q2	$1.24M	Hold	43,889	–	–	﹤0.01%	820
2025 Q1	$1.41M	Hold	43,889	–	–	﹤0.01%	786
2024 Q4	$1.08M	Hold	43,889	–	–	﹤0.01%	861
2024 Q3	$1.13M	Hold	43,889	–	–	﹤0.01%	858
2024 Q2	$1.07M	Hold	43,889	–	–	﹤0.01%	864
2024 Q1	$1.41M	Hold	43,889	–	–	﹤0.01%	814
2023 Q4	$1.4M	Buy	43,889 +1,272	+3%	+$30.2K	﹤0.01%	843
2023 Q3	$1.09M	Buy	42,617 +2,617	+7%	+$80.6K	﹤0.01%	861
2023 Q2	$1.06M	Buy	+40,000	New	+$1.09M	﹤0.01%	864
2022 Q3	–	Sell	-26,100	Closed	-$402K	–	1374
2022 Q2	$402K	Hold	26,100	–	–	﹤0.01%	1059
2022 Q1	$719K	Buy	26,100 +2,400	+10%	+$61.2K	﹤0.01%	979
2021 Q4	$920K	Buy	23,700 +600	+3%	+$24.4K	﹤0.01%	947
2021 Q3	$1.08M	Buy	23,100 +15,000	+185%	+$672K	﹤0.01%	887
2021 Q2	$280K	Hold	8,100	–	–	﹤0.01%	1158
2021 Q1	$314K	Hold	8,100	–	–	﹤0.01%	1109
2020 Q4	$343K	Buy	+8,100	New	+$549K	﹤0.01%	1099
2016 Q2	–	Sell	-1,929	Closed	-$49K	–	989
2016 Q1	$49K	Buy	+1,929	New	+$65.3K	﹤0.01%	1024

Other funds holding ARCT

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ARCT Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Arcturus Therapeutics (ARCT) in Q1 2026, closing a stake of 43,889 shares — an estimated $1.24M sold.

DekaBank Deutsche Girozentrale first reported a position in ARCT in Q1 2016 and held it in 19 quarters. The position peaked at $1.41M in Q1 2025. 124 funds tracked by Wall St. Rank hold ARCT as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Arcturus Therapeutics position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 43,889 Arcturus Therapeutics shares in Q1 2026, an estimated $1.24M.
DekaBank Deutsche Girozentrale first reported a position in Arcturus Therapeutics in Q1 2016 and held it in 19 quarters.
DekaBank Deutsche Girozentrale's Arcturus Therapeutics position peaked at $1.41M in Q1 2025.
124 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.